iPSCs are being tested for various conditions, including Parkinson's disease, cancer immunotherapies with iNK cells, age-related ... Cellular Therapy: iPSCs are being explored for cell therapy ...

We're trying to set the stage for integrating these ideas" Anthony Vella, professor and Boehringer Ingelheim Chair in ...

The automated and closed cell therapy processing systems market is experiencing rapid growth, driven by the increasing demand for regenerative medicine and the need for advanced, scalable ...

A paradigm shift in the way we treat spinal injuries is now in sight, with the world's first regenerative cell therapy being granted approval for a registrational Phase I clinical trial.

Orca Bio is preparing to make a splash in the cell therapy market. The biotech has hired Steve Gavel as chief commercial officer, securing itself a leader with cell therapy expertise accrued at ...

Co., Ltd. officially announced that XellSmart-developed off-the-shelf allogeneic iPSC-derived subtype-specific neural regenerative cell therapy has received official approval from both China's ...

So, when Quartey learned of a newly FDA-approved gene therapy to treat Sickle Cell Disease, she was all in. Gerald Quartey, 18, recently became the first patient to receive Lyfgenia, a one-time ...

As favor in the general market swings away from cell therapy, Immatics’ CEO is choosing to focus on what he can control: raising the bar for his biotech’s investigational treatment.